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Abstract
Background: L. braziliensis causes cutaneous (CL) and mucosal (ML) leishmaniasis. Wound healing neutrophil (PMN)
and macrophage responses made following the bite of the vector sand fly contribute to disease progression in
mice. To look at the interplay between PMN and macrophages in disease progression in humans we asked
whether polymorphisms at genes that regulate their infiltration or function are associated with different clinical
phenotypes. Specifically, CXCR1 (IL8RA) and CXCR2 (IL8RB) are receptors for chemokines that attract PMN to
inflammatory sites. They lie 30-260 kb upstream of SLC11A1, a gene known primarily for its role in regulating
macrophage activation, resistance to leishmaniasis, and wound healing responses in mice, but also known to be
expressed in PMN, macrophages and dendritic cells.
Methods: Polymorphic variants at CXCR1, CXCR2 and SLC11A1 were analysed using Taqman or ABI fragment
separation technologies in cases (60 CL; 60 ML), unrelated controls (n = 120), and multicase families (104 nuclear
families; 88 ML, 250 CL cases) from Brazil. Logistic regression analysis, family-based association testing (FBAT) and
haplotype analysis (TRANSMIT) were performed.
Results: Case-control analysis showed association between the common C allele (OR 2.38; 95% CI 1.23-4.57; P =
0.009) of CXCR1_rs2854386 and CL, supported by family-based (FBAT; Z score 2.002; P = 0.045) analysis (104
nuclear families; 88 ML, 250 CL cases). ML associated with the rarer G allele (Z score 1.999; P = 0.046). CL associated
with a 3’ insertion/deletion polymorphism at SLC11A1 (Z score 2.549; P = 0.011).
Conclusions: The study supports roles for CXCR1 and SLC11A1 in the outcome of L. braziliensis infection in humans.
Slc11a1 does not influence cutaneous lesion development following needle injection of Leishmania in mice,
suggesting that its role here might relate to the action of PMN, macrophage and/or dendritic cells in the wound
healing response to the sand fly bite. Together with the CXCR1 association, the data are consistent with
hypotheses relating to the possible role of PMN in initiation of a lesion following the delivery of parasites via the
sand fly bite. Association of ML with the rare derived G allele suggests that PMN also have an important positive
role to play in preventing this form of the disease.
Background
Leishmania infection is associated with a broad spec-
trum of clinical phenotypes and many studies have
demonstrated that host genetic factors play a part in
determining the outcome of infection (reviewed [1-3]).
L. braziliensis infection causes cutaneous leishmaniasis
(CL) with prolonged time to lesion healing. Pro-inflam-
matory cytokines, including tumor necrosis factor (TNF)
and interferon-g (IFN-g), and macrophage activation are
important in eventual self-healing, but an exaggerated
response is associated with mucosal leishmaniasis (ML)
[4,5]. Pro-inflammatory responses elicited by polymor-
phonuclear neutrophils (PMN) as part of the wound
healing response to the bite of the sand fly vector are
important in initiation of lesion development in mice
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[6]. It has been hypothesized [7] that differences in the
ability of macrophages and dendritic cells from different
inbred mouse strains to respond to apoptotic versus
necrotic PMN arising during the wound healing
response to an infected sand fly bite determines disease
progression. The arrival and maintenance of infiltrating
cells at bite sites is thought to be mediated by sand fly-
derived factors that either mimic a tissue damage signal
or activate chemokine/chemokine receptor pathways
[8-10]. Expression patterns for chemokines have been
associated with the evolution of large and small lesions
in mice following L. braziliensis infection, influenced by
both the strain of parasite [10] and the mouse genetic
background [8].
One way to look at the interplay between PMN and
macrophages in disease progression in humans is to
determine whether polymorphisms at genes that regu-
late their infiltration or function are associated with dif-
ferent clinical phenotypes following infection with
Leishmania spp. CXCR1 (IL8RA) and CXCR2 (IL8RB)
are receptors for chemokines that attract PMN to
inflammatory sites. They lie on human Chromosome
2q25 230-260 kb upstream of SLC11A1, a gene that reg-
ulates macrophage activation and resistance to visceral
leishmaniasis (reviewed reference [11]) as well as wound
healing responses in mice [12]. Here we report on a
small case-control study, underpinned by family-based
analysis, which provides evidence for separate roles for
CXCR1 and SLC11A1 in determining susceptibility to
leishmaniasis caused by L. braziliensis in Brazil.
Methods
The study was conducted in the area of Corte de Pedra,
Bahia, Brazil, where L. braziliensis is endemic. Corte de
Pedra is in a region of rural rain forest, where agricul-
ture underpins the local economy. Around 3300 subjects
were interviewed during 4 years to select the study
population. For this genetics study, both case-control
and family-based cohorts were studied. Index cases of
ML were ascertained from medical records of the Corte
de Pedra Public Health Post. The case definition of ML
is a characteristic mucosal lesion with either parasitolo-
gical confirmation or two of the three following criteria:
positive delayed-type hypersensitivity test (DTH), posi-
tive leishmania serology, and a histopathology suggestive
of leishmaniasis. All cases in the current study also
responded to antileishmanial therapy. The families and
neighborhoods of these ML patients were revisited, to
establish the study population. CL is defined as the pre-
sence of a single chronic ulcerative lesion at a skin site
without evidence of mucosal involvement, and without
evidence of dissemination to 10 or more sites (dissemi-
nated leishmaniasis), also confirmed by detection of
parasites or two of the three criteria listed above. Past
cases that have been treated in the health post of Corte
de Pedra have their diagnoses confirmed by medical
records using the same criteria defined above, and all
cases were examined for detection of a characteristic
well delimited scar. Informed consent was obtained
from all the participants, and the research was approved
by the ethical committee of the Hospital Universitário
Professor Edgard Santos, Salvador, Brazil. Demographi-
cal, epidemiological and phenotype characteristics of
these subjects were previously described in full [13].
DNA was available from 60 ML index cases (47 males:
13 females; mean age ± SD = 40 ± 17 years), 60 age-
and gender-matched unrelated CL cases (47 males: 13
females; mean age ± SD = 41 ± 17.8 years), 60 age- and
sex-matched unrelated individuals (47 males: 13 females;
mean age ± SD = 38 ± 18 years) positive for the leish-
manin delayed hypersensitivity skin-test response (DTH
+) and with no current or previous history of CL or ML
disease, and 60 unrelated neighbourhood controls (47
males: 13 females; mean age ± SD = 40 ± 18 years).
These neighborhood controls (NC) also had no clinical
history of disease or leishmaniasis scars, but their leish-
manin skin test status was unknown. For some of the
case-control analyses the two patient groups, CL and
ML, were analysed together to determine susceptibility
to L. braziliensis per se, and the DTH+ and NC groups
pooled as the unaffected controls. This 120 cases com-
pared to 120 controls analysis had ≥65% power to detect
an odds ratio ≥2 at P = 0.01 for markers with minor
allele frequency (MAF) ≥0.2. The smaller comparison of
60 cases compared to 60 controls had ≥55% power to
detect an odds ratio ≥2 at P = 0.05 for markers with
minor allele frequency (MAF) ≥0.2. The 60 ML index
cases were also used to ascertain a total of 67 multi-case
leishmaniasis (mixed for CL and ML) pedigrees (104
nuclear families), providing a total of 88 ML cases (i.e.
28 additional cases; 15 of the 88 cases had no observable
scar for prior CL disease) and 250 CL cases (exclusive of
the 60 CL cases used in the case-control study. Thus the
family study is used to validate associations for ML seen
in the case-control analysis, while the CL sample in
families is independent and can be used to replicate
observations made in the case-control analysis. TDT
power approximations [14] show that the 250 CL cases
in 104 nuclear families had ≥85% power to detect an
odds ratio ≥2 at P = 0.01 for markers with minor allele
frequency ≥0.2. It is possible that some CL cases in our
study could progress to ML disease at a later date. Epi-
demiological studies show that this will affect <4% of
CL patients [15], thus representing a small reduction in
the power of our study to detect CL-specific genetic
effects. Full demographic and epidemiological informa-
tion in relation to multi-case families used in this study
have been presented elsewhere [16].
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Genotyping was performed in Cambridge using Taq-
man or ABI fragment separation technologies for poly-
morphisms at CXCR1, CXCR2 and SLC11A1 as
presented in Table 1. Genotype data are available on
request for meta-analysis. All were in Hardy Weinberg
Equilibrium in genetically unrelated founders of the
families, and in the unrelated neighborhood controls
(data not shown). Case-control data were analysed using
logistic regression analysis. PEDCHECK [17] was used
to determine Mendelian inconsistencies within families.
Inconsistencies due to mis-paternities had already been
removed as part of previous studies [13] (L. Castellucci,
unpublished PhD thesis). Mendelian inconsistencies for
individual markers in this study were due to errors
(<2%) that occur in calling Taqman genotyping and
were set to zero for analysis. Family-based allelic asso-
ciation tests based on the transmission disequilibrium
test (TDT) but generalized to allow analysis under addi-
tive and dominant models of inheritance were per-
formed within FBAT [18,19] under the null hypothesis
of “no linkage and no association”. Unaffected members
of the pedigrees were included in the study, contributing
genotype information to increase statistical power of the
FBAT analysis, especially for families with missing par-
ents. Family-based haplotype TDT was performed using
TRANSMIT [20]. Nominal P-values are presented
throughout, i.e. without correction for multiple testing.
Results
The case-control groups had similar demographics,
including age, duration of residence in the endemic
area, housing and main occupation. The environmental
exposures surveyed were also similar between the two
family cohorts, except for house distance from the forest
that was different between the CL (265.2 meters) and
ML groups (144.1 meters) (P = 0.04, unpaired t test),
but not between the ML group and the NC or DTH-
positive groups, as fully described elsewhere [13].
Table 2 presents the results of the case-control logistic
regression analysis. SNP rs2854386 at CXCR1 was asso-
ciated with susceptibility to CL, but not to ML, when
each of these patient groups was compared with either
the NC, the DTH+, or the combined NC+DTH+ control
groups. CL is associated (OR 2.38; 95% CI 1.19-3.40;
global P = 0.006) with the common C allele. Analysis
for susceptibility to L. braziliensis per se (i.e. CL+ML
compared to NC+DTH+) did not improve the signifi-
cance (Table 2) suggesting that, although CL disease
usually precedes ML disease, there was something differ-
ent about the ML patient group which meant that they
did not contribute to this association. Similarly, signifi-
cance observed at rs2854386 for CL disease under a
dominant model in the FBAT analysis (Table 3) was not
improved when the data were analysed for susceptibility
to L. braziliensis per se. CL disease was associated with
Table 1 Information on the polymorphic markers genotyped for CXCR1, CXCR2 and SLC11A1.
Gene/Marker Physical Position (bp) Alleles1 MAF Caucasian Asian African
CXCR2_rs4674259
(5’ UTR)
218699250 T>C 0.388 0.517 0.341 0.883
CXCR1_rs2854386
3’ region
218735747 C>G 0.218 0.058 0.100 0.425
CXCR1_rs2234671
Exon 1 S276T
218737353 C>G 0.194 0.058 0.100 0.317
CXCR1_rs3138060
Intron 1
218739745 G>C 0.142 0.058 0.102 0.129
SLC11A1_rs7573065
(-237 bp 5’ UTR)
218954951 C>T 0.0903 - - 04
SLC11A1_rs2276631
(2742; exon 3, Phe66Phe)
218957257 C>T 0.289 0.224 0.102 0.127
SLC11A1_rs3731865
(469+14G/C2; intron 4)
218958247 G>C 0.227 0.272 0.082 0.1204
SLC11A1_rs17221959
(8232; exon 8, Gly249Gly)
218960874 C>T 0.266 0.022 0.152 0.3104
SLC11A1_rs2279015
(1465-85G/A2; intron 13)
218967514 C>T 0.379 0.342 0.307 0.942
SLC11A1_rs17235409
(17032; exon 15, D543N)
218967976 G>A 0.0893 0.012 0.182 0.1204
SLC11A1_ rs17235416
(1729+55del42; 3’ UTR TGTG IN/DEL)
218968058 IN/DEL 0.176 0.012 0.182 0.1884
Physical positions of markers are given according to Build 36.3 of the human genome. Where available, allele frequencies for the minor allele (MAF) in Brazil are
shown for Caucasian, Asian and African populations (Hapmap CEU, JPT and YRI unless otherwise referenced). 1 Major>minor alleles for this Brazilian population; 2
[21], bp positions of variants relative to an arbitrary site 76 bp upstream of the methionine start codon; 3Allele frequency too low to be taken forward in the
association analyses; 4[31].
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the common C allele. Interestingly, in this analysis,
transmission disequilibrium of alleles from heterozygous
parents to ML disease patients only (Table 3) showed
disease associated with the opposite G allele at
rs2854386, suggesting opposing influences on the role of
this gene in CL versus ML disease. This was principally
determined by disease associated with the dominant G
allele in heterozygotes (FBAT Z score 2.221; P = 0.026)
in the genotype analysis, with the homozygous recessive
CC genotype being protective for ML (FBAT Z score =
-1.999; P = 0.04). This was measurable in the family-
based analysis but the genotype-wise test (not shown)
was not valid in the case-control analysis due to the
smaller sample size. Similar but weaker allele-wise asso-
ciations were observed in the case-control analysis for
SNP CXCR1_rs2234671 (Table 2), which is in strong
(but not complete) linkage disequilibrium with
CXCR1_rs2854386 in the family founders (Figure 1) and
unrelated NC controls (data not shown) in our study.
CXCR1_rs2234671 did not achieve significance for CL
disease in the FBAT analysis (Table 3), but the presence
of the G allele in the heterozygous genotype conferred
disease association for ML (FBAT score 1.964; P =
0.049). Haplotype analysis (Table 4) across the 3
CXCR2/CXCR1 markers rs467259_rs2854386_rs2234671
confirmed that the common haplotype T_C_C
(frequency 0.47) was significantly over-transmitted to
individuals in the families with CL only (c21df = 6.62; P
= 0.01) and significantly under-transmitted to indivi-
duals in the families with ML (c21df = 4.42; P = 0.04),
consistent with the case-control analysis (Table 2) that
showed ML associated with the rarer C allele at
CXCR2_rs4674259 (OR = 1.82; 95% CI 1.07-3.07; global
P = 0.023). Inclusion of the CXCR2 SNP rs4674259 was
necessary to observe the haplotype associations, which
were not explained by over- or under-transmission of
the shorter C_C haplotype for rs2854386_rs2234671
(Table 4). The opposing effects of polymorphism at
CXCR1/2 on CL and ML was clearly neutralized in ana-
lysis of haplotype transmission to the combined CL+ML
group (Table 4).
At SLC11A1, none of the polymorphisms showed
association with either CL or ML disease in the case-
control logistic regression analysis (Table 2). Association
between the SLC11A1 1729+55del4 [21] IN/DEL and
CL (FBAT Z score +2.198 for the IN/IN homozygous
genotype, P = 0.028) but not ML disease was observed
in the family-based analysis (Table 3), again with the
ML group not apparently contributing to the associa-
tion. The disease allele is the common insertion allele,
which is recessive, while the deletion is protective under
the dominant model. Given the low level of linkage
r’D 2
Figure 1 Haploview analysis for D’ and r2 pairwise measures of LD between CXCR2, CXCR1 and SLC11A1 SNPs and IN/DEL in family
founders from the study population in Brazil. D’ values and confidence levels (LOD) are represented as black for D’ = 1, LOD>2; shades of
pink for high D’, LOD<2; white for D’<1, LOD<2. r2 values are represented as black for r2 = 1, white for r2 = 0, with intermediate values for 0<r2
< 1 indicated by shades of grey. The numbers within the squares represent the D’ or r2 scores for pairwise LD.
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disequilibrium between the 1729+55del4 IN/DEL and
rs2854386 (Figure 1), the associations observed between
CL and SLC11A1 and between CL and CXCR1 are likely
to be independent. There was insufficient power in the
sample to determine whether these two loci had inde-
pendent effects, or whether there was any interaction
between them.
Discussion
The study presented here has provided interesting preli-
minary data which support roles for both CXCR1 and
SLC11A1 in determining the outcome of L. braziliensis
infection. Although the FBAT analysis supported the
case-control analysis for CXCR1, the power of our study
was limited by small sample size and MAF < 0.2 for the
markers (rs2854386, rs2234671) of particular interest. In
the context of the admixed population found in Brazil,
the family-based analysis provides some confidence that
the results are not due to mismatch between case and
control groups. For that reason, we also have some con-
fidence in the association between SLC11A1 observed in
the more powerful family-based analysis for CL disease,
even though this was not replicated in the case-control
analysis. Further replication studies in larger cohorts
will be essential to validate our results. Nevertheless, the
data provide interesting insight into the possible roles of
PMN and macrophages in leishmaniasis caused by L.
braziliensis.
At present we do not know the functional basis to the
association between CXCR1 rs2854386 and CL versus
ML disease. This SNP lies in the 3’ region of the
CXCR1 gene, adjacent to rs4674259 in the 5’ region of
the CXCR2 gene. Opposing over- and under-transmitted
associations with the common ancestral T_C_C haplo-
types for CL and ML, but not the shorter C_C haplo-
types, suggests location of the functional variant in the
Table 2 Results of logistic regression analysis
Gene/Marker Groups Compared Allele OR 95% CI Global P value
CXCR2_rs4674259 CL vs DTH C vs T 1.03 0.60-1.76 0.908
CL vs NC C vs T 0.91 0.53-1.58 0.752
ML vs DTH C vs T 1.92 1.05-3.51 0.028
ML vs NC C vs T 1.71 0.93-3.14 0.076
CL vs DTH+NC C vs T 0.97 0.60-1.56 0.909
ML vs DTH+NC C vs T 1.82 1.07-3.07 0.023
CL+ML vs DTH+NC C vs T 1.26 0.85-1.88 0.239
CXCR1_rs2854386 CL vs DTH C vs G 2.31 1.07-4.96 0.027
CL vs NC C vs G 2.48 1.21-5.10 0.009
ML vs DTH C vs G 1.55 0.72-3.35 0.254
ML vs NC C vs G 1.72 0.84-3.54 0.127
CL vs DTH+NC C vs G 2.38 1.23-4.57 0.006
ML vs DTH+NC C vs G 1.63 0.84-3.14 0.132
CL+ML vs DTH+NC C vs G 2.01 1.19-3.40 0.007
CXCR1_rs2234671 CL vs DTH C vs G 2.06 0.93-4.56 0.069
CL vs NC C vs G 1.91 0.89-4.10 0.087
ML vs DTH C vs G 1.73 0.74-4.01 0.190
ML vs NC C vs G 1.62 0.72-3.63 0.226
CL vs DTH+NC C vs G 1.96 0.98-3.89 0.044
ML vs DTH+NC C vs G 1.66 0.79-3.46 0.160
CL+ML vs DTH+NC C vs G 1.84 1.04-3.23 0.030
SLC11A1_rs 17235416 CL vs DTH DEL vs IN 1.35 0.63-2.87 0.428
CL vs NC DEL vs IN 0.87 0.42-1.79 0.714
ML vs DTH DEL vs IN 1.10 0.53-2.30 0.781
ML vs NC DEL vs IN 0.73 0.35-1.48 0.383
CL vs DTH+NC DEL vs IN 1.07 0.57-1.99 0.820
ML vs DTH+NC DEL vs IN 0.88 0.47-1.66 0.709
CL+ML vs DTH+NC DEL vs IN 0.97 0.58-1.62 0.929
Under an additive model for case-control comparisons of CL, ML and L. braziliensis per se (CL+ML) disease groups with NC, DTH+ or NC+DTH+ control groups.
Only the data for markers where significant associations (P = 0.05; bold) were observed in this or the family-based (Table 3) analysis are shown. OR = odds ratio;
CI = 95% confidence interval.
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regulatory region between the genes that could affect
expression of either of them. Although CXCR1
rs2854386 is in strong linkage disequilibrium with
rs2234671, which encodes a mis-sense mutation that
alters the amino acid sequence from Ser-to-Thr at posi-
tion 276 of the protein, the haplotype analysis did not
support over- and under-transmission of the C_C haplo-
type between these two markers as the reason for the
opposing associations. Interestingly, the allele
frequencies for the minor allele (MAF) for rs2854386
(0.218) and rs2234671 (0.194) observed in Brazil were
high compared to those observed in Caucasian (CEU)
(0.058 for both) and Asian (JPT) populations (0.100 for
both), perhaps reflecting the contribution of African
haplotypes (e.g. YRI MAFs 0.425 and 0.317, respectively)
to the Brazilian population near Salvador, a city with a
significant population of African origin. Failure to see
complete concordance between the results at these two
Table 3 FBAT analysis of family data
Gene/Marker Phenotype Model Allele/Genotype Allele/Genotype
Frequency
# Families Obs T Exp T Z score P value
CXCR1_rs2854386 CL Dominant C 0.83 12 35 29 2.002 0.045
ML Dominant G 0.17 20 17 12 1.999 0.046
ML Genotype CC 0.69 20 7 12 -1.999 0.046
ML Genotype CG1 0.28 22 18 12 2.221 0.026
CL+ML Dominant C 0.83 12 35 29 2.002 0.045
CXCR1_rs2234671 CL Dominant C 0.85 12 36 32 1.563 0.118
ML Dominant G 0.15 18 14 11 1.604 0.108
ML Genotype CG 0.30 19 14 9 1.964 0.049
CL+ML Dominant C 0.85 12 36 32 1.563 0.118
SLC11A1_rs 17235416 CL Additive IN 0.86 27 98 88 2.549 0.011
ML Additive IN 0.86 21 32 32 0.209 0.834
CL+ML Additive IN 0.86 28 105 95 2.333 0.020
CL Dominant DEL 0.14 24 30 12 -2.198 0.028
ML Dominant DEL 0.14 19 9 10 -0.426 0.670
CL+ML Dominant DEL 0.14 25 25 32 -2.179 0.029
CL Genotype IN/IN 0.75 24 35 27 2.198 0.028
CL Genotype IN/DEL2 0.23 27 28 33 -1.206 0.228
ML Genotype IN/IN 0.75 19 12 11 0.426 0.670
ML Genotype IN/DEL2 0.23 21 8 10 -1.021 0.307
CL+ML Genotype IN/IN 0.75 25 38 30 2.179 0.029
CL+ML Genotype IN/DEL2 0.23 28 29 34 -1.409 0.159
FBAT analysis for transmission of alleles from heterozygous parents to CL, ML and L. braziliensis per se (CL and ML) individuals in families. # families = number of
families informative for the FBAT analysis. A positive Z score indicates association with disease; a negative Z score indicates the non-associated or protective
allele or genotype. Obs T = observed transmissions; Exp T = expected transmissions. 1Insufficient informative families (# = 4) for the GG genotype (frequency
0.03) to contribute to the analysis; 2Insufficient informative families (# = 5,4,5) for the DEL/DEL genotype (frequency 0.02) to contribute to the analysis for CL, ML
or CL+ML.
Table 4 Haplotype analysis of family data
Disease Phenotype Haplotypes Haplotype Frequency Over/Under Transmitted rs4674259 rs2854386 rs2234671
CL T_C 0.47 Over O = 160; E = 145; c21df = 5.88; P = 0.015
C_C 0.16 - O = 62; E = 67; c21df = 2.02; NS
T_C_C 0.47 Over O = 152; E = 136; c21df = 6.62; P = 0.010
ML T_C 0.47 Under O = 41; E = 49; c21df = 5.19; P = 0.023
C_C 0.16 - O = 17; E = 15; c21df = 0.08; NS
T_C_C 0.47 Under O = 39; E = 46; c21df = 4.22; P = 0.040
CL or ML T_C 0.47 - O = 201; E = 194; c21df = 0.96; NS
C_C 0.16 - O = 80; E = 82; c21df = 1.36; NS
T_C_C 0.47 - O = 190; E = 181; c21df = 1.59; NS
TRANSMIT haplotype association analysis for SNPs rs4674259_rs2854386_rs2234671 across CXCR2_CXCR1 showing over- and under-transmission for the common
haplotypes in families analysed for the CL only phenotype, ML only phenotype, and CL or ML. O = observed number of transmissions; E = expected number of
transmissions.
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markers in our analysis could be due to differences in
genotyping success between individuals, or to the pre-
sence of African haplotypes. Association of CL with the
common ancestral T_C_C haplotype suggests that dis-
ease is associated with a fully functional variant, and
hence that influx of PMN is associated with CL disease.
This is consistent with data [6] and hypotheses [7] relat-
ing to the possible role of PMN in initiation of a lesion
following the delivery of parasites via the sand fly bite.
Association of ML with the rare derived G allele, which
we assume to be the functionally compromised allele/
haplotype, suggests that PMN may have an important
positive role to play in preventing this form of the dis-
ease. Recent studies have shown, for example, that PMN
can play an important role in initiating and regulating
innate immune defences that protect mucosal surfaces
from fungal infection [22]. Failure to protect the mucosa
from early invasion and injury could result in local pre-
sentation of antigen and amplification of the acquired T
cell-mediated proinflammatory response that is asso-
ciated with ML disease.
The association of CL disease with the common 1729
+55del4 IN variant at SLC11A1 is also of interest in
relation to the putative role of this molecule, which is
expressed in mature macrophages [23], dendritic cells
[24] and PMN [25], in regulating expression of secretory
leukocyte protease inhibitor and hence affecting the
wound healing response [12]. Differences in lesion
development have not been observed following subcuta-
neous needle injection of either L. major [26] or L. mex-
icana [27] into Slc11a1 congenic mice, suggesting that
the genetic influence of SLC11A1 on susceptibility to
CL following natural infection in humans might be
mediated by the effect on the wound healing response
to the sand fly bite. This means that the mechanism by
which SLC11A1 influences CL disease may be different
to its influence on visceral leishmaniasis in mice follow-
ing intravenous needle injection [28], or in natural infec-
tion of dogs [29,30] and humans [31,32], consistent with
its many pleiotropic effects [11]. Our study was not suf-
ficiently powered to look for interaction between the
CXCR1 and SLC11A1 in this study, and further work
will be needed to determine whether the association at
SLC11A1 relates to its role in PMN, macrophages or
dendritic cells at the site of infection. For the present,
our study begins to provide novel insight to the possible
role of PMN in lesion development of leishmaniasis
caused by L. braziliensis infection in Brazil.
Conclusions
The study supports roles for CXCR1 (IL8RA) and
SLC11A1 in the outcome of L. braziliensis infection in
humans. Previous data in mice showing that Slc11a1
does not influence cutaneous lesion development
following needle injection of Leishmania suggests that its
role here might relate to the action of PMN, macrophage
and/or dendritic cells in the wound healing response to
the sand fly bite. Together with the CXCR1 association,
the data are consistent with hypotheses relating to the
possible role of PMN in initiation of a lesion following
the delivery of parasites via the sand fly bite. Association
of ML with the rare derived G allele at CXCR1 rs2854386
suggests that PMN also have an important positive role
to play in preventing this form of the disease.
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